Merck settlement includes ACCME policies agreement

Share this article:
Merck's settlement of Vioxx litigation with 29 states included agreements to abide by ACCME policies regarding disclosure of relationships between speakers and companies and not to fund programs featuring speakers who have spoken at a Merck-sponsored promotional event on a drug in the relevant class within the last 12 months. The settlement commits Merck to these conditions for nine years. 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.